OR WAIT null SECS
Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.
April 30, 2010
A new automated factory in Boston (MA, USA) has been developed that uses non-genetically modified green plants to quickly produce large quantities of vaccines and therapeutics.
After completing the first phase of a project designed to increase the consistency and transparency of the EU regulatory process, the European Medicines Agency (EMA) has published a summary report that includes suggestions for improving the current processes for evaluating benefit?risk.
April 29, 2010
The European Medicines Agency published a summary report that includes suggestions for improving the current processes for evaluating benefit-risk.
April 28, 2010
AstraZeneca has finalized its agreement with US federal and state entities, under which it will pay $520 million to resolve allegations that it marketed the anti-psychotic drug Seroquel for off-label uses.
April 23, 2010
An evaluation conducted by Ernst & Young assessing the effectiveness and efficiency of the European Medicines Agency has largely praised the agency; however, a number of strategic and operational recommendations for further improvements have also been made.
Despite pharma's upcoming peak years of patent expiries and the threat of generic competition, growth during the next 5 years is expected to be strong with the global market for pharmaceuticals forecast to reach more than $1 trillion by 2014, according to IMS Health.